- Home
- CVKD vs FENG Comparison
CVKD vs FENG Comparison
Compare CVKD & FENG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CVKD
- FENG
- Stock Information
- Founded
- CVKD 2022
- FENG 1998
- Country
- CVKD United States
- FENG China
- Employees
- CVKD N/A
- FENG N/A
- Industry
- CVKD Medicinal Chemicals and Botanical Products
- FENG Broadcasting
- Sector
- CVKD Health Care
- FENG Industrials
- Exchange
- CVKD Nasdaq
- FENG Nasdaq
- Market Cap
- CVKD 29.5M
- FENG 26.8M
- IPO Year
- CVKD 2023
- FENG 2011
- Fundamental
- Price
- CVKD $12.80
- FENG $2.39
- Analyst Decision
- CVKD Strong Buy
- FENG
- Analyst Count
- CVKD 1
- FENG 0
- Target Price
- CVKD $32.00
- FENG N/A
- AVG Volume (30 Days)
- CVKD 34.6K
- FENG 4.5K
- Earning Date
- CVKD 08-11-2025
- FENG 08-12-2025
- Dividend Yield
- CVKD N/A
- FENG N/A
- EPS Growth
- CVKD N/A
- FENG N/A
- EPS
- CVKD N/A
- FENG N/A
- Revenue
- CVKD N/A
- FENG $101,168,374.00
- Revenue This Year
- CVKD N/A
- FENG N/A
- Revenue Next Year
- CVKD N/A
- FENG N/A
- P/E Ratio
- CVKD N/A
- FENG N/A
- Revenue Growth
- CVKD N/A
- FENG 5.53
- 52 Week Low
- CVKD $6.89
- FENG $1.28
- 52 Week High
- CVKD $22.90
- FENG $3.49
- Technical
- Relative Strength Index (RSI)
- CVKD 53.26
- FENG 59.30
- Support Level
- CVKD $12.02
- FENG $2.19
- Resistance Level
- CVKD $14.10
- FENG $2.35
- Average True Range (ATR)
- CVKD 0.88
- FENG 0.12
- MACD
- CVKD 0.13
- FENG 0.02
- Stochastic Oscillator
- CVKD 63.38
- FENG 77.55
About CVKD Cadrenal Therapeutics Inc.
Cadrenal Therapeutics Inc is developing tecarfarin, its drug candidate, for unmet needs in anticoagulation therapy. Tecarfarin is a late-stage novel oral and reversible anticoagulant (blood thinner) designed to prevent heart attacks, strokes, and deaths due to blood clots in patients with rare cardiovascular conditions requiring chronic anticoagulation.
About FENG Phoenix New Media Limited
Phoenix New Media Ltd is a media company providing premium content on an integrated platform across the internet, mobile and TV channels in China. The company organizes its operations into two main segments: Net advertising services and Paid services. It provides its content and services through three channels: ifeng.com channel, video channel, and mobile channel. The company also offers a wide range of paid services including mobile value-added services, games, and content sales. It generates the majority of its revenue from Net advertising services. Geographically, it derives revenue from China.